Sign Out
Sustained-release capsule: Severe skin lesions such as Stevens-Johnson syndrome and Lyell's syndrome have been reported rarely with the administration of mucolytics such as ambroxol. These may be due to the severity of the underlying disease or concomitant medication. If new skin or mucosal lesions occur, discontinue ambroxol and consult a physician immediately. The medicine should not be taken if the patient is pregnant or breastfeeding unless advised by a doctor.
Syrup: Should be used with care in patients with a history of peptic ulceration.
Continue with Google